arrow
I

Ivan Odak

Hannover Medical School
H指数:14
被引数:1,299

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine
2024-01-012
OAAI
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals
2023-05-056
OAAI
Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19
2023-02-019
OAAI
Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML relapse

治疗性供者淋巴细胞输注的光谱流式细胞术聚类分析可鉴定与AML复发患者预后相关的T细胞亚群

2022-10-057
OAAI
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
2022-08-1825
OAAI
Longitudinal Tracking of Immune Responses in COVID-19 Convalescents Reveals Absence of Neutralization Activity Against Omicron and Staggered Impairment to Other SARS-CoV-2 Variants of Concern
2022-03-149
OAAI
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents
2021-11-1140
OAAI
Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI

CD8 T细胞的克隆扩增反映了移植物抗白血病活性,并在DLI后持续缓解

2021-11-089
OAAI
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
2021-07-14314
OAAI
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
2021-06-2367
OAAI
Reappearance of effector T cells is associated with recovery from COVID-19
2020-07-0196
OAAI